
FDA Grants Orphan Drug Designation to PEP-010 in Pancreatic Cancer
The Food and Drug Administration (FDA) has granted orphan drug designation to PEP-010 — a first-in-class bifunctional therapeutic peptide — for the treatment of patients with pancreatic cancer, according to a recent news release from the drug’s …